Exec Chat: Philips's Bert Van Meurs Discusses Innovation And Plans For Image-Guided Therapy Business Unit
Executive Summary
This year, Bert van Meurs, chief business leader of Philips's image-guided therapy business, has led two major product launches and a new partnership with Microsoft to combine Philips's Azurion angiographic platform with Microsoft's HoloLens 2 mixed-reality (MR) technology. Medtech Insight caught up with van Meurs to learn more about Azurion, the continued role of machine learning and MR, the overall business strategy and competitive landscape.
You may also be interested in...
Philips Goes Fishing For Start-Ups With Healthtech AI Ambitions
Royal Philips has launched a global artificial intelligence collaboration program with start-up companies that will allow innovators in the area to work with the group's global innovation hubs. The company is looking to build and scale promising ideas and consider them for further collaboration.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.